Stock Region Penny Picks
Your Weekly Stock Region Penny Picks Watchlist Highlights - Thursday, May, 22 2025.
Your Weekly Stock Region Penny Picks Watchlist Highlights - Thursday, May, 22 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions.
$DGXX - Digi Power X Subsidiary Collaboration
US Data Centers Inc., a Digi Power X subsidiary, partners with Super Micro for the initial deployment of the customized B200 GPU infrastructure. This could signal growth opportunities in high-performance computing.
$OSRH - Blockchain-Based Token Launch
OSR Holdings collaborates with BCM Europe and the Taekwondo Cooperative to launch the blockchain-powered OSRH token under a new strategic memorandum of understanding (MOU).
$GRI - Strong Pre-Clinical Results
GRI Bio showcases positive pre-clinical data for GRI-0621, highlighting its effectiveness in reducing inflammation and fibrosis. Promising Phase 2a clinical data reinforces its potential in therapeutic applications.
$GNS - Bitcoin Strategy Expansion
Genius Group increases its Bitcoin treasury by 40%. If you're watching crypto-related stocks, this development could be of interest.
$BDRX - $3M Grant Boost
Biodexa announces an additional $3M CPRIT grant for its Phase 3 eRapa program, bringing total funding to $20M. Backing for its research initiatives remains strong.
$BON - New Product Launch
BON rolls out Tea Pigment Digestive Health products while securing a cooperation agreement with Shanghai Risesun International Trade. This could boost its health product portfolio.
$LAES - Secure Element Launch
SEALSQ introduces the MS6003 Secure Element with preloaded FIDO2 technology, pushing forward passwordless authentication in alignment with zero-trust security models. A volume spike of 4.13 was recorded earlier this week.
$IMMX - ASCO 2025 Presentation
IMMX announces that its NXC-201 therapy will be presented at ASCO 2025. The showcased trial results underscore promising progress for treating AL Amyloidosis.
Stay informed and ahead of the market with these updates.
Disclaimer: Stock Region is not responsible for any trading decisions based on this information. Always consult a financial advisor and perform due diligence before investing.
© 2025 Stock Region